Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed May 19, 2017
Insider Transaction Report
Form 4
Verguet Patrick B
CVP, Europe
Transactions
- Exercise/Conversion
Common Stock
2017-05-17$44.62/sh+8,000$356,920→ 141,768.15 total - Sale
Common Stock
2017-05-17$113.21/sh−4,631$524,272→ 137,137.15 total - Sale
Common Stock
2017-05-17$113.15/sh−8,000$905,221→ 129,137.15 total - Exercise/Conversion
Common Stock
2017-05-19$44.62/sh+10,000$446,150→ 139,137.15 total - Sale
Common Stock
2017-05-19$113.13/sh−10,000$1,131,346→ 129,137.15 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-17−8,000→ 58,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (8,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-19−10,000→ 48,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $113.2091 to $113.2150. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $113.1340 to $113.1550. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $113.00 to $113.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.